Literature DB >> 20122875

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

T Jared Bunch1, J Peter Weiss, Brian G Crandall, Heidi T May, Tami L Bair, Jeffrey S Osborn, Jeffrey L Anderson, Joseph B Muhlestein, Benjamin D Horne, Donald L Lappe, John D Day.   

Abstract

BACKGROUND: The aging population has resulted in more patients living with cardiovascular disease, such as atrial fibrillation (AF). Recent focus has been placed on understanding the long-term consequences of chronic cardiovascular disease, such as a potential increased risk of dementia.
OBJECTIVE: This study sought to determine whether there is an association between AF and dementia and whether their coexistence is an independent marker of risk.
METHODS: A total of 37,025 consecutive patients from the large ongoing prospective Intermountain Heart Collaborative Study database were evaluated and followed up for a mean of 5 years for the development of AF and dementia. Dementia was sub-typed into vascular (VD), senile (SD), Alzheimer's (AD), and nonspecified (ND).
RESULTS: Of the 37,025 patients with a mean age of 60.6 +/- 17.9 years, 10,161 (27%) developed AF and 1,535 (4.1%) developed dementia (179 VD, 321 SD, 347 AD, 688 ND) during the 5-year follow-up. Patients with dementia were older and had higher rates of hypertension, coronary artery disease, renal failure, heart failure, and prior strokes. In age-based analysis, AF independently was significantly associated with all dementia types. The highest risk was in the younger group (<70). After dementia diagnosis, the presence of AF was associated with a marked increased risk of mortality (VD: hazard ratio [HR] = 1.38, P = .01; SD: HR = 1.41, P = .001; AD: HR = 1.45; ND: HR = 1.38, P <.0001).
CONCLUSION: AF was independently associated with all forms of dementia. Although dementia is strongly associated with aging, the highest risk of AD was in the younger group, in support of the observed association. The presence of AF also identified dementia patients at high risk of death. Copyright 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20122875     DOI: 10.1016/j.hrthm.2009.12.004

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  97 in total

Review 1.  Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis.

Authors:  Shadi Kalantarian; Hakan Ay; Randy L Gollub; Hang Lee; Kallirroi Retzepi; Moussa Mansour; Jeremy N Ruskin
Journal:  Ann Intern Med       Date:  2014-11-04       Impact factor: 25.391

2.  Nurse-Enhanced Memory Intervention in Heart Failure: the MEMOIR study.

Authors:  Susan J Pressler; Barbara Therrien; Penny L Riley; Cheng-Chen Chou; David L Ronis; Todd M Koelling; Dean G Smith; Barbara Jean Sullivan; Ann-Marie Frankini; Bruno Giordani
Journal:  J Card Fail       Date:  2011-10       Impact factor: 5.712

Review 3.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

4.  Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.

Authors:  Jan W Schrickel; Markus Linhart; Dietmar Bänsch; Daniel Thomas; Georg Nickenig
Journal:  Clin Res Cardiol       Date:  2015-10-29       Impact factor: 5.460

5.  [Management and therapy of atrial fibrillation in geriatric patients].

Authors:  M Gosch; R E Roller; B Böhmdorfer; U Benvenuti-Falger; B Iglseder; M Lechleitner; U Sommeregger; P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

6.  The cognitive impact of atrial fibrillation.

Authors:  Anne F Gross; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-01-10

7.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

8.  Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation.

Authors:  Khang-Li Looi; Parag Gajendragadkar; Tamer Taha; Maros Elsik; Elizabeth Scully; Patrick Heck; Simon Fynn; Munmohan Virdee; David Begley
Journal:  J Interv Card Electrophysiol       Date:  2012-10-25       Impact factor: 1.900

Review 9.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

Review 10.  Vascular cognitive impairment.

Authors:  Muhammad U Farooq; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.